Prostate and Urologic Cancer Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer Cholecalciferol, Genistein, Laboratory Biomarker Analysis, Pharmacological Study, Placebo NCT01325311 National Cancer Institute (NCI) Completed
Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove... defined green tea catechin extract, placebo, immunohistochemistry staining method, immunoenzyme technique, laboratory biomarker analysis, biopsy, mass spectrometry, high performance liquid chromatography NCT00459407 National Cancer Institute (NCI) Completed
Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer diindolylmethane, placebo, therapeutic conventional surgery, laboratory biomarker analysis, pharmacological study NCT00450229 National Cancer Institute (NCI) Completed
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery Finasteride, Placebo, Prostatectomy, Laboratory biomarker analysis NCT00438464 National Cancer Institute (NCI) Completed
Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer Defined Green Tea Catechin Extract, Laboratory Biomarker Analysis, Pharmacological Study, Placebo, Therapeutic Conventional Surgery NCT00666562 National Cancer Institute (NCI) Completed
Lovastatin in Treating Patients At High Risk of Melanoma lovastatin, placebo, biopsy, laboratory biomarker analysis NCT00462280 National Cancer Institute (NCI) Completed
Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer placebo, therapeutic conventional surgery, laboratory biomarker analysis, lycopene NCT00450749 National Cancer Institute (NCI) Completed
Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery metformin hydrochloride, placebo, laboratory biomarker analysis NCT01433913 National Cancer Institute (NCI) Completed
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer genistein, laboratory biomarker analysis, placebo, therapeutic conventional surgery, pharmacological study NCT00118040 National Cancer Institute (NCI) Completed
Pomegranate-Extract Pill in Preventing Tumor Growth in Patients With Localized Prostate Cancer... Laboratory Biomarker Analysis, Pharmacological Study, Placebo, Pomegranate-Extract Pill NCT02095145 National Cancer Institute (NCI) Active, not recruiting

Pages